Psoriasis Latest Advances

Real-world effectiveness of risankizumab in psoriasis: first Sardinian multicenter 2-year experience.

Journal: Italian journal of dermatology and venereology

Published: June 23, 2026

Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial.

Journal: The Journal of dermatological treatment

Published: June 23, 2026

Correction: Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 21, 2026

Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis.

Journal: The Journal of dermatological treatment

Published: June 20, 2026

Optimising biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

Journal: Expert opinion on biological therapy

Published: June 20, 2026

Influence of fungi on epithelial homeostasis and role in inflammatory diseases.

Journal: Clinical microbiology reviews

Published: June 18, 2026

Global burden of skin and subcutaneous disease across childhood and adolescence in 204 countries and territories, 1990-2021.

Journal: JAAD international

Published: June 17, 2026

Corrigendum: Keratin 17 enhances the chemotaxis of neutrophils through regulating CXCL1 secretion in keratinocytes via PI3K/AKT/NF-κB pathway in psoriasis.

Journal: Chinese medical journal

Published: June 16, 2026

Keratinocyte-Derived Apoptotic Nanovehicles Reprogram Cutaneous Dendritic Cells to Ameliorate Psoriasis.

Journal: ACS nano

Published: June 16, 2026

Clinical and histopathologic characteristics and outcomes of patients with Psoriatic Arthritis undergoing arthroplasty.

Journal: The Journal of rheumatology

Published: June 15, 2026

Insufficient or excessive exercise activities are associated with suboptimal treatment outcomes in patients with psoriasis: a longitudinal study in shanghai, China.

Journal: Annals of medicine

Published: June 15, 2026

Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease.

Journal: The Journal of rheumatology

Published: June 15, 2026

Psoriasis Latest Advances

Find the Latest Research About Psoriasis

Real-world effectiveness of risankizumab in psoriasis: first Sardinian multicenter 2-year experience.

Real-world effectiveness of risankizumab in psoriasis: first Sardinian multicenter 2-year experience.

Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial.

Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial.

Correction: Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels.

Correction: Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels.

Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis.

Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis.

Optimising biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

Optimising biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

Influence of fungi on epithelial homeostasis and role in inflammatory diseases.

Influence of fungi on epithelial homeostasis and role in inflammatory diseases.

Global burden of skin and subcutaneous disease across childhood and adolescence in 204 countries and territories, 1990-2021.

Global burden of skin and subcutaneous disease across childhood and adolescence in 204 countries and territories, 1990-2021.

Corrigendum: Keratin 17 enhances the chemotaxis of neutrophils through regulating CXCL1 secretion in keratinocytes via PI3K/AKT/NF-κB pathway in psoriasis.

Corrigendum: Keratin 17 enhances the chemotaxis of neutrophils through regulating CXCL1 secretion in keratinocytes via PI3K/AKT/NF-κB pathway in psoriasis.

Keratinocyte-Derived Apoptotic Nanovehicles Reprogram Cutaneous Dendritic Cells to Ameliorate Psoriasis.

Keratinocyte-Derived Apoptotic Nanovehicles Reprogram Cutaneous Dendritic Cells to Ameliorate Psoriasis.

Clinical and histopathologic characteristics and outcomes of patients with Psoriatic Arthritis undergoing arthroplasty.

Clinical and histopathologic characteristics and outcomes of patients with Psoriatic Arthritis undergoing arthroplasty.

Insufficient or excessive exercise activities are associated with suboptimal treatment outcomes in patients with psoriasis: a longitudinal study in shanghai, China.

Insufficient or excessive exercise activities are associated with suboptimal treatment outcomes in patients with psoriasis: a longitudinal study in shanghai, China.

Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease.

Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease.